← All trials
NCT05102123
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2022
- Primary completion
- Oct 1, 2024
- Completion date
- Apr 1, 2025
- First posted
- Nov 1, 2021
- Last posted
- Nov 1, 2021
- Enrollment
- 1720
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- McMaster UniversityLead sponsor
- McMaster UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.